These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 17096589

  • 21. Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damage.
    Barbosa FM, Fonseca FL, Holandino C, Alviano CS, Nimrichter L, Rodrigues ML.
    Microbes Infect; 2006 Feb; 8(2):493-502. PubMed ID: 16293436
    [Abstract] [Full Text] [Related]

  • 22. A Predicted Mannoprotein Participates in Cryptococcus gattii Capsular Structure.
    Reuwsaat JCV, Motta H, Garcia AWA, Vasconcelos CB, Marques BM, Oliveira NK, Rodrigues J, Ferrareze PAG, Frases S, Lopes W, Barcellos VA, Squizani ED, Horta JA, Schrank A, Rodrigues ML, Staats CC, Vainstein MH, Kmetzsch L.
    mSphere; 2018 Apr 25; 3(2):. PubMed ID: 29897877
    [Abstract] [Full Text] [Related]

  • 23. Isolation and purification of antigenic components of Cryptococcus.
    Wozniak KL, Levitz SM.
    Methods Mol Biol; 2009 Apr 25; 470():71-83. PubMed ID: 19089377
    [Abstract] [Full Text] [Related]

  • 24. Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen.
    Martinez LR, Moussai D, Casadevall A.
    Infect Immun; 2004 Jun 25; 72(6):3674-9. PubMed ID: 15155683
    [Abstract] [Full Text] [Related]

  • 25. Antibodies to keyhole limpet hemocyanin cross-react with an epitope on the polysaccharide capsule of Cryptococcus neoformans and other carbohydrates: implications for vaccine development.
    May RJ, Beenhouwer DO, Scharff MD.
    J Immunol; 2003 Nov 01; 171(9):4905-12. PubMed ID: 14568972
    [Abstract] [Full Text] [Related]

  • 26. Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.
    Maitta RW, Datta K, Lees A, Belouski SS, Pirofski LA.
    Infect Immun; 2004 Jan 01; 72(1):196-208. PubMed ID: 14688097
    [Abstract] [Full Text] [Related]

  • 27. Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis.
    Fonseca FL, Guimarães AJ, Kmetzsch L, Dutra FF, Silva FD, Taborda CP, Araujo Gde S, Frases S, Staats CC, Bozza MT, Schrank A, Vainstein MH, Nimrichter L, Casadevall A, Rodrigues ML.
    Fungal Genet Biol; 2013 Nov 01; 60():64-73. PubMed ID: 23608320
    [Abstract] [Full Text] [Related]

  • 28. Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct.
    Albuquerque PC, Fonseca FL, Dutra FF, Bozza MT, Frases S, Casadevall A, Rodrigues ML.
    Future Microbiol; 2014 Nov 01; 9(2):147-61. PubMed ID: 24571070
    [Abstract] [Full Text] [Related]

  • 29. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.
    Rodrigues ML, Nimrichter L, Oliveira DL, Frases S, Miranda K, Zaragoza O, Alvarez M, Nakouzi A, Feldmesser M, Casadevall A.
    Eukaryot Cell; 2007 Jan 01; 6(1):48-59. PubMed ID: 17114598
    [Abstract] [Full Text] [Related]

  • 30. The Overlooked Glycan Components of the Cryptococcus Capsule.
    Fonseca FL, Reis FCG, Sena BAG, Jozefowicz LJ, Kmetzsch L, Rodrigues ML.
    Curr Top Microbiol Immunol; 2019 Jan 01; 422():31-43. PubMed ID: 30203395
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A.
    Sundstrom JB, Cherniak R.
    Infect Immun; 1993 Apr 01; 61(4):1340-5. PubMed ID: 8095924
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Dectin-3 Recognizes Glucuronoxylomannan of Cryptococcus neoformans Serotype AD and Cryptococcus gattii Serotype B to Initiate Host Defense Against Cryptococcosis.
    Huang HR, Li F, Han H, Xu X, Li N, Wang S, Xu JF, Jia XM.
    Front Immunol; 2018 Apr 01; 9():1781. PubMed ID: 30131805
    [Abstract] [Full Text] [Related]

  • 36. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.
    Nimrichter L, Frases S, Cinelli LP, Viana NB, Nakouzi A, Travassos LR, Casadevall A, Rodrigues ML.
    Eukaryot Cell; 2007 Aug 01; 6(8):1400-10. PubMed ID: 17573547
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.